Bavarian Nordic Sues Oxford BioMedica Over Patents

Law360, New York (July 1, 2008, 12:00 AM EDT) -- A year after Bavarian Nordic settled a global patent feud with Acambis over a smallpox vaccine, the biopharmaceutical company is suing Oxford BioMedica Inc. over patents related to the same virus.

Denmark-based Bavarian Nordic owns several patents related to a virus known as MVA-BN, which is used for its small pox vaccine and can be also used as a vector to deliver vaccines against cancer and other diseases.

MVA-BN's patented properties prevent it from replicating in human cells, making it a relatively safe delivery system for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.